Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/51110
Type
ArticleCopyright
Restricted access
Collections
Metadata
Show full item record26
CITATIONS
26
Total citations
4
Recent citations
2.87
Field Citation Ratio
1.08
Relative Citation Ratio
ANTIBODY SIGNATURES REFLECT DIFFERENT DISEASE PATHOLOGIES IN PATIENTS WITH SCHISTOSOMIASIS DUE TO SCHISTOSOMA JAPONICUM
Author
Affilliation
QIMR Berghofer Medical Research Institute. Brisbane, Australia
QIMR Berghofer Medical Research Institute. Brisbane, Australia/Hunan Institute of Parasitic Diseases. Yueyang, China
Centre for Biodiscovery and Molecular Development of Therapeutics. Australian Institute of Tropical Health and Medicine. Queensland Tropical Health Alliance Laboratory. James Cook University., Cairns, Australia/ Centro de Pesquisas René Rachou. Oswaldo Cruz Foundation. Belo Horizonte, MG, Brazil
Centre for Biodiscovery and Molecular Development of Therapeutics. Australian Institute of Tropical Health and Medicine. Queensland Tropical Health Alliance Laboratory. James Cook University. Cairns, Australia
University of California. Irvine, CA, USA
QIMR Berghofer Medical Research Institute. Brisbane, Australia
QIMR Berghofer Medical Research Institute. Brisbane, Australia
University of California. Irvine, CA, USA
Hunan Institute of Parasitic Diseases. Yueyang, China
QIMR Berghofer Medical Research Institute. Brisbane, Australia/Institute for Molecular Biosciences, University of Queensland. St. Lucia, Australia
University of California. Irvine, CA, USA
QIMR Berghofer Medical Research Institute. Brisbane, Australia
Centre for Biodiscovery and Molecular Development of Therapeutics. Australian Institute of Tropical Health and Medicine. Queensland Tropical Health Alliance Laboratory. James Cook University. Cairns, Australia
QIMR Berghofer Medical Research Institute. Brisbane, Australia
QIMR Berghofer Medical Research Institute. Brisbane, Australia/Hunan Institute of Parasitic Diseases. Yueyang, China
Centre for Biodiscovery and Molecular Development of Therapeutics. Australian Institute of Tropical Health and Medicine. Queensland Tropical Health Alliance Laboratory. James Cook University., Cairns, Australia/ Centro de Pesquisas René Rachou. Oswaldo Cruz Foundation. Belo Horizonte, MG, Brazil
Centre for Biodiscovery and Molecular Development of Therapeutics. Australian Institute of Tropical Health and Medicine. Queensland Tropical Health Alliance Laboratory. James Cook University. Cairns, Australia
University of California. Irvine, CA, USA
QIMR Berghofer Medical Research Institute. Brisbane, Australia
QIMR Berghofer Medical Research Institute. Brisbane, Australia
University of California. Irvine, CA, USA
Hunan Institute of Parasitic Diseases. Yueyang, China
QIMR Berghofer Medical Research Institute. Brisbane, Australia/Institute for Molecular Biosciences, University of Queensland. St. Lucia, Australia
University of California. Irvine, CA, USA
QIMR Berghofer Medical Research Institute. Brisbane, Australia
Centre for Biodiscovery and Molecular Development of Therapeutics. Australian Institute of Tropical Health and Medicine. Queensland Tropical Health Alliance Laboratory. James Cook University. Cairns, Australia
QIMR Berghofer Medical Research Institute. Brisbane, Australia
Abstract
Infection with Schistosoma japonicum causes high levels of pathology that is predominantly determined by the cellular and humoral response of the host. However, the specific antibody response that arises during the development of disease is largely undescribed in Asian schistosomiasis-endemic populations. A schistosome protein microarray was used to compare the antibody profiles of subjects with acute infection, with early or advanced disease associated with severe pathology, with chronic infection, and subjects exposed but stool negative for S. japonicum eggs to the antibody profiles of nonexposed controls. Twenty-five immunodominant antigens were identified, including vaccine candidates, tetraspanin-related proteins, transporter molecules, and unannotated proteins. Additionally, individuals with severe pathology had a limited specific antibody response, suggesting that individuals with mild disease may use a broad and strong antibody response, particularly against surface-exposed proteins, to control pathology and/or infection. Our study has identified specific antigens that can discriminate between S. japonicum-exposed groups with different pathologies and may also allow the host to control disease pathology and provide resistance to parasite infection
Share